|
1
|
Lee HS, Woo SJ, Koh HW, Ka SO, Zhou L,
Jang KY, Lim HS, Kim HO, Lee SI and Park BH: Regulation of
apoptosis and inflammatory responses by insulin-like growth factor
binding protein 3 in fibroblast-like synoviocytes and experimental
animal models of rheumatoid arthritis. Arthritis Rheumatol.
66:863–873. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Firestein GS: Evolving concepts of
rheumatoid arthritis. Nature. 423:356–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meier FM, Frerix M, Hermann W and
Müller-Ladner U: Current immunotherapy in rheumatoid arthritis.
Immunotherapy. 5:955–974. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Riccaboni M, Bianchi I and Petrillo P:
Spleen tyrosine kinases: biology, therapeutic targets and drugs.
Drug Discov Today. 15:517–530. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan S, Liao C, Lucas C, Stevenson C and
DeMartino JA: Targeting the SYK-BTK axis for the treatment of
immunological and hematological disorders: recent progress and
therapeutic perspectives. Pharmacol Ther. 138:294–309. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moon SJ, Park JS, Woo YJ, Lim MA, Kim SM,
Lee SY, Kim EK, Lee HJ, Lee WS, Park SH, Jeong JH, et al:
Rebamipide suppresses collagen-induced arthritis through reciprocal
regulation of th17/treg cell differentiation and heme oxygenase 1
induction. Arthritis Rheumatol. 66:874–885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Criado G, Risco A, Alsina-Beauchamp D,
Pérez-Lorenzo MJ, Escós A and Cuenda A: Alternative p38 MAPKs are
essential for collagen-induced arthritis. Arthritis Rheumatol.
66:1208–1217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spurgeon SE, Coffey G, Fletcher LB, Burke
R, Tyner JW, Druker BJ, Betz A, DeGuzman F, Pak Y, Baker D, Pandey
A, et al: The selective SYK inhibitor P505-15 (PRT062607) inhibits
B cell signaling and function in vitro and in vivo and augments the
activity of fludarabine in chronic lymphocytic leukemia. J
Pharmacol Exp Ther. 344:378–387. 2013. View Article : Google Scholar :
|
|
9
|
Tak PP, Smeets TJ, Daha MR, Kluin PM,
Meijers KA, Brand R, Meinders AE and Breedveld FC: Analysis of the
synovial cell infiltrate in early rheumatoid synovial tissue in
relation to local disease activity. Arthritis Rheum. 40:217–225.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Souza PP and Lerner UH: The role of
cytokines in inflammatory bone loss. Immunol Invest. 42:555–622.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaur M, Singh M and Silakari O: Inhibitors
of switch kinase ‘spleen tyrosine kinase’ in inflammation and
immune-mediated disorders: a review. Eur J Med Chem. 67:434–446.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ghosh D and Tsokos GC: Spleen tyrosine
kinase: an Src family of non-receptor kinase has multiple functions
and represents a valuable therapeutic target in the treatment of
autoimmune and inflammatory diseases. Autoimmunity. 43:48–55. 2010.
View Article : Google Scholar
|
|
13
|
Hoellenriegel J, Coffey GP, Sinha U,
Pandey A, Sivina M, Ferrajoli A, Ravandi F, Wierda WG, O’Brien S,
Keating MJ and Burger JA: Selective, novel spleen tyrosine kinase
(Syk) inhibitors suppress chronic lymphocytic leukemia B-cell
activation and migration. Leukemia. 26:1576–1583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jakus Z, Simon E, Balázs B and Mócsai A:
Genetic deficiency of Syk protects mice from autoantibody-induced
arthritis. Arthritis Rheum. 62:1899–1910. 2010.PubMed/NCBI
|
|
15
|
Chauhan AK and Moore TL: Immune complexes
and late complement proteins trigger activation of Syk tyrosine
kinase in human CD4(+) T cells. Clin Exp Immunol. 167:235–245.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng GM, Liu L, Bahjat FR, Pine PR and
Tsokos GC: Suppression of skin and kidney disease by inhibition of
spleen tyrosine kinase in lupus-prone mice. Arthritis Rheum.
62:2086–2092. 2010.PubMed/NCBI
|
|
17
|
Ulanova M, Asfaha S, Stenton G, Lint A,
Gilbertson D, Schreiber A and Befus D: Involvement of Syk protein
tyrosine kinase in LPS-induced responses in macrophages. J
Endotoxin Res. 13:117–125. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stenton GR, Ulanova M, Déry RE, Merani S,
Kim MK, Gilchrist M, Puttagunta L, Musat-Marcu S, James D,
Schreiber AD and Befus AD: Inhibition of allergic inflammation in
the airways using aerosolized antisense to Syk kinase. J Immunol.
169:1028–1036. 2002. View Article : Google Scholar : PubMed/NCBI
|
